glp 1 court case FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Fight over GLP-1 compounding plays

A pilot study in young adults found that lion mane supplementation improved processing speed, and researchers attributed this partly to BDNF-like neurotrophic effects

The dose may be adjusted up to a maximum of 3 mg per day, based on clinical response and tolerability (Table 1) [16,45]

November 20, 2025: Ozempic Vision Loss and Gastroparesis Lawsuits Consolidated in New Jersey The New Jersey Supreme Court has approved the creation of two multicounty litigations (MCLs) involving Ozempic

Potential Interaction Risks and Safety Considerations The primary safety concern with dual therapy is additive gastrointestinal side effects: both sermorelin and tirzepatide can cause nausea, vomiting, and delayed gastric emptying

This suggested potential metal chelating and antioxidant activities of RJ 26